Broom A, Gibson A F, Broom J, Kirby E, Yarwood T, Post J J
School of Social Sciences, University of New South Wales, Sydney, NSW, Australia.
School of Social Sciences, University of New South Wales, Sydney, NSW, Australia.
J Hosp Infect. 2016 Nov;94(3):230-235. doi: 10.1016/j.jhin.2016.08.021. Epub 2016 Aug 31.
Antibiotic optimization in hospitals is an increasingly critical priority in the context of proliferating resistance. Despite the emphasis on doctors, optimizing antibiotic use within hospitals requires an understanding of how different stakeholders, including non-prescribers, influence practice and practice change.
This study was designed to understand Australian hospital managers' perspectives on antimicrobial resistance, managing antibiotic governance, and negotiating clinical vis-à-vis managerial priorities.
Twenty-three managers in three hospitals participated in qualitative semi-structured interviews in Australia in 2014 and 2015. Data were systematically coded and thematically analysed.
The findings demonstrate, from a managerial perspective: (1) competing demands that can hinder the prioritization of antibiotic governance; (2) ineffectiveness of audit and monitoring methods that limit rationalization for change; (3) limited clinical education and feedback to doctors; and (4) management-directed change processes are constrained by the perceived absence of a 'culture of accountability' for antimicrobial use amongst doctors.
Hospital managers report considerable structural and interprofessional challenges to actualizing antibiotic optimization and governance. These challenges place optimization as a lower priority vis-à-vis other issues that management are confronted with in hospital settings, and emphasize the importance of antimicrobial stewardship (AMS) programmes that engage management in understanding and addressing the barriers to change.
在耐药性不断增加的背景下,医院抗生素的优化使用已成为日益关键的优先事项。尽管重点在于医生,但在医院内优化抗生素使用需要了解包括非开处方者在内的不同利益相关者如何影响实践及实践变革。
本研究旨在了解澳大利亚医院管理人员对抗菌药物耐药性、抗生素管理以及在临床与管理优先事项之间进行协调的看法。
2014年和2015年,澳大利亚三家医院的23名管理人员参与了定性半结构化访谈。对数据进行系统编码并进行主题分析。
从管理角度来看,研究结果表明:(1)相互竞争的需求可能会阻碍抗生素管理的优先排序;(2)审核和监测方法的无效性限制了变革的合理化;(3)对医生的临床教育和反馈有限;(4)管理主导的变革过程受到医生中抗菌药物使用“问责文化”缺失观念的制约。
医院管理人员报告称,在实现抗生素优化和管理方面存在重大的结构和跨专业挑战。这些挑战使得优化相对于医院管理面临的其他问题成为较低优先级,并强调了抗菌药物管理(AMS)计划的重要性,该计划促使管理层理解并解决变革的障碍。